Skip to Main Content

Paper Details

A Second Opinion From Observational Data on Second-line Diabetes Drugs.
JAMA Netw Open
1
2018
Diabetes
Author NameAffiliation
Alison CallahanCenter for Biomedical Informatics Research, Stanford University School of Medicine
Nigam H ShahCenter for Biomedical Informatics Research, Stanford University School of Medicine
Nigam H ShahCenter for Biomedical Informatics Research, Stanford University School of Medicine
  • 1 - 3

Datasets